“FCGBP Inhibits the Development of LSCC and Cisplatin Resistance through the PIGR JAK2 STAT3 Pathway”. 2026. Radiology and Oncology 60 (1): 67-75. https://radioloncol.com/index.php/ro/article/view/4672.